posterolateral spine fusion
Recently Published Documents


TOTAL DOCUMENTS

39
(FIVE YEARS 2)

H-INDEX

10
(FIVE YEARS 0)

2021 ◽  
Author(s):  
Sreedhara Sangadala ◽  
Chi Heon Kim ◽  
Lorenzo M Fernandes ◽  
Pooja Makkara ◽  
Scott D Boden ◽  
...  

Background: The healing environment within the posterolateral lumbar spine is one of the most clinically challenging bone healing environments in all of orthopaedics due to a lack of a contained space and the need to form de novo bone in a nonbony environment. Our group has previously published data that suggests that sclerostin in expressed locally at high levels throughout the process of a spinal fusion mass maturing. Methods: We computationally identified multiple FDA approved drugs, as well as a novel drug, for their ability to disrupt the interaction between sclerostin and its receptor, LRP5/6. The drugs were tested in several in vitro biochemical assays using murine MC3T3 and MSCs, assessing their ability to (1) enhance canonical Wnt signaling, (2) promote the accumulation of the active (non-phosphorylated) form of B-catenin, and (3) enhance the intensity and signaling duration of BMP signaling. These drugs were then tested subcutaneously in rats as standalone osteoinductive agents on plain collagen sponges. Finally, the top drug candidates (called VA1 and C07) were tested in a rabbit posterolateral spine fusion model for their ability to achieve a successful fusion. Results: We show that by controlling GSK3b phosphorylation, these SMIs simultaneously enhance canonical Wnt signaling and potentiate canonical BMP signaling intensity and duration. We also demonstrate that the SMIs produce dose-dependent ectopic mineralization in vivo in rats as well as significantly increase posterolateral spine fusion rates in rabbits in vivo, both as standalone osteogenic drugs and in combination with autologous iliac crest bone graft. Conclusions: Few if any osteogenic small molecules have been described that possess the osteoinductive potency of BMP itself - that is, the ability to form de novo ectopic bone as a standalone agent, particularly in stringent in vivo environments. Herein, we describe two such SMIs that have this unique ability and thus may have potential application as novel cost-effective biologic bone graft substitutes for achieving consistent spinal fusion or even or critical-sized fracture defects.


2019 ◽  
Vol 34 (3) ◽  
pp. 365-374 ◽  
Author(s):  
Ming Ding ◽  
Kariatta Esther Koroma ◽  
Jesper Roed Sorensen ◽  
Monica Sandri ◽  
Anna Tampieri ◽  
...  

2019 ◽  
Vol 19 (4) ◽  
pp. 762-771
Author(s):  
Tsai-Sheng Fu ◽  
Ying-Chih Wang ◽  
Chien-Hao Chen ◽  
Chia-Wei Chang ◽  
Tung-Yi Lin ◽  
...  

2018 ◽  
Vol 0 (2) ◽  
pp. 13-21
Author(s):  
Volodymyr Radchenko ◽  
Artem Skidanov ◽  
Nataliya Ashukina ◽  
Zinaida Danyshchuk ◽  
Marina Nessonova ◽  
...  

2017 ◽  
Vol 17 (6) ◽  
pp. 855-862 ◽  
Author(s):  
Antonio T. Brecevich ◽  
Paul D. Kiely ◽  
B. Victor Yoon ◽  
Joseph T. Nguyen ◽  
Frank P. Cammisa ◽  
...  

2015 ◽  
Vol 15 (9) ◽  
pp. 2036-2044 ◽  
Author(s):  
Tsai-Sheng Fu ◽  
Yu-Han Chang ◽  
Chak-Bor Wong ◽  
I-Chun Wang ◽  
Tsung-Ting Tsai ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Hiroto Kamoda ◽  
Tetsuhiro Ishikawa ◽  
Masayuki Miyagi ◽  
Yawara Eguchi ◽  
Sumihisa Orita ◽  
...  

We present a rare case of delayed onset of epidural hematoma after lumbar surgery whose only presenting symptom was vesicorectal disturbance. A 68-year-old man with degenerative spinal stenosis underwent lumbar decompression and instrumented posterolateral spine fusion. The day after his discharge following an unremarkable postoperative course, he presented to the emergency room complaining of difficulty in urination. An MRI revealed an epidural fluid collection causing compression of the thecal sac. The fluid was evacuated, revealing a postoperative hematoma. After removal of the hematoma, his symptoms disappeared immediately, and his urinary function completely recovered. Most reports have characterized postoperative epidural hematoma as occurring early after operation and accompanied with neurological deficits. But it can happen even two weeks after spinal surgery with no pain. Surgeons thus may need to follow up patients for at least a few weeks because some complications, such as epidural hematomas, could take that long to manifest themselves.


Sign in / Sign up

Export Citation Format

Share Document